Get started
Author

Mazen Tolaymat

The Role of M3 Muscarinic Receptor Ligand-Induced Kinase Signaling in Colon Cancer Progression
2019 · Mazen Tolaymat, Shannon M. Larabee, et al. · Cancers · 36
PDF
Proactive Drug Monitoring Is Associated With Higher Persistence to Infliximab and Adalimumab Treatment and Lower Healthcare Utilization Compared With Reactive and Clinical Monitoring
2020 · Nauroz Syed, Mazen Tolaymat, et al. · Crohn s & Colitis 360 · 30
PDF
Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer
2021 · Osman Ali, Mazen Tolaymat, et al. · International Journal of Molecular Sciences · 21
PDF
Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases
2021 · Mazen Tolaymat, Margaret H. Sundel, et al. · Frontiers in Pharmacology · 18
PDF
Prevalence and Risk Factors for Choledocholithiasis After Cholecystectomy
2017 · Joseph Spataro, Mazen Tolaymat, et al. · The American Journal of Gastroenterology · 13
Randomized controlled pilot study of feasibility and effectiveness of peer led remote Mindfulness‐Based Art Workshops on stress, anxiety, and depression in medical students
2022 · Chaoyang Wang, Isha Darbari, et al. · Psychology in the Schools · 11
Muscarinic receptor agonist-induced βPix binding to β-catenin promotes colon neoplasia
2023 · Kunrong Cheng, Ahmed Chahdi, et al. · Scientific Reports · 10
PDF
Targeted intestinal deletion of Rho guanine nucleotide exchange factor 7, βPIX, impairs enterocyte proliferation, villus maturation, and mucosal defenses in mice
2021 · Kunrong Cheng, Shannon M. Larabee, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 6
S2895 Unique Presentation of Colonic Single Stripe Sign
2024 · Sanya Badar, Saba Altarawneh, et al. · The American Journal of Gastroenterology · 1
The Impact of Intermediate Antidrug Antibodies to Infliximab and Adalimumab on Clinical Outcomes in Patients with Crohn’s Disease or Ulcerative Colitis
2022 · Chaoyang Wang, Mazen Tolaymat, et al. · European Medical Journal · 1
PDF
The Impact of Intermediate Titer Antibodies to Adalimumab (ata) and Infliximab (ati) on Clinical Outcomes in Patients With Crohn’s Disease (cd) or Ulcerative Colitis (uc)
2021 · Chaoyang Wang, Mazen Tolaymat, et al. · Gastroenterology
The Impact of Intermediate Titer Antibodies to Adalimumab (ata) and Infliximab (ati) on Clinical Outcomes in Patients With Crohn’s Disease (cd) or Ulcerative Colitis (uc)
2021 · Chaoyang Wang, Mazen Tolaymat, et al. · Inflammatory Bowel Diseases
Sa1887 PROACTIVE DRUG MONITORING IS ASSOCIATED WITH HIGHER PERSISTENCE TO INFLIXIMAB AND ADALIMUMAB TREATMENT AND LOWER HEALTHCARE UTILIZATION COMPARED TO REACTIVE AND CLINICAL MONITORING
2020 · Nauroz Syed, Mazen Tolaymat, et al. · Gastroenterology
145 CONSTITUTIVE BINDING OF βPAK-INTERACTING EXCHANGE FACTOR (βPIX) TO β-CATENIN IN COLON CANCER MODULATES GENE TRANSCRIPTION AND IS AUGMENTED BY ACTIVATING M3 MUSCARINIC RECEPTORS (M3R)
2020 · Kunrong Cheng, Shannon M. Larabee, et al. · Gastroenterology
271 TARGETED DELETION OF THE CDC42/RAC NUCLEOTIDE EXCHANGE FACTOR, βPAK-INTERACTING EXCHANGE FACTOR (βPIX), IMPAIRS SMALL INTESTINAL EPITHELIAL CELL PROLIFERATION, DEVELOPMENT OF VILLI, AND ENTEROID SURVIVAL
2020 · Shannon M. Larabee, Kunrong Cheng, et al. · Gastroenterology
Mo1032 THE CDC42/RAC NUCLEOTIDE EXCHANGE FACTOR, βPAK-INTERACTING EXCHANGE FACTOR (βPIX), PLAYS AN IMPORTANT ROLE IN PROTECTING THE INTESTINAL EPITHELIAL SURFACE FROM CAUSTIC INJURY
2020 · Mazen Tolaymat, Kunrong Cheng, et al. · Gastroenterology
Symptomatic Choledocholithiasis After Cholecystectomy
2017 · Joseph Spataro, Mazen Tolaymat, et al. · The Medicine Forum
Works count: 17
Citation count: 147
H-index: 7
I10-index: 7
Year
Topic
Type